Home › Products › Oncology › Doceco 120mg Injection
Doceco 120mg Injection
Salt Composition: DOCETAXEL
- Manufacturer: PHARMACO INDUSTRIES PVT. LTD.
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 120MG
- Prescription Required
- Storage: Keep Doceco 120mg Injection out of sight and reach of children. Do not store above 25°C.
₹1485.00₹16500.00
Inclusive of all taxes
Product Introduction
Doceco 120mg Injection is an anticancer medication belonging to the taxoid class. It contains Docetaxel and is indicated for the treatment of breast, prostate, non-small cell lung, stomach, and head and neck cancers. Cancer is characterised by uncontrolled and abnormal cell multiplication. This chemotherapy agent may be used as monotherapy or in combination with other anticancer medicines. Common side effects associated with Doceco 120mg Injection include dizziness, headache, fever, infections, loss of appetite, insomnia, joint or muscle pain, eye problems, weight loss, fatigue, dry mouth, hypotension, and alopecia. Inform your doctor if any of these side effects occur or persist. Notify your doctor of any known allergy to Doceco 120mg Injection or its components. Prior to treatment initiation, disclose to your physician any history of kidney disease, cardiac problems, vision disturbances, epilepsy, or alcohol dependence. Doceco 120mg Injection is contraindicated in patients with severe neutropenia or severe hepatic disease. Inform your physician of all concurrent medications, including supplements and herbal products, before commencing Doceco 120mg Injection treatment. Effective contraception must be used during treatment and for at least six months following the final dose.
Uses
The Doceco 120mg Injection is used in the treatment of the following: Non-small cell lung cancer Breast cancer Stomach or gastric cancer Prostate cancer Head and neck cancer
How it works
Doceco 120mg Injection works by targeting the tiny tube-like structures inside cancer cells called microtubules. These microtubules are important for helping cancer cells divide and grow. By blocking them, Doceco 120mg Injection slows down the growth of cancer cells and eventually leads to their destruction.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Doceco 120mg Injection are: Severe allergic reactions Severe fluid retention Severe skin problems Swelling of the small intestine and colon Common side effects of Doceco 120mg Injection are: Headache, dizziness Fever, infections Low blood cell count Loss of appetite Trouble sleeping Joint or muscle pain Alteration in the sense of taste Eye problems, bleeding from the nose Nausea, vomiting Diarrhea, constipation Abdominal pain Hair loss, change in color of your nails Change or absence of menstrual period Weight loss Tiredness Dry mouth High blood sugar Decreased blood pressure, rapid heartbeat
Expert Tips
It is advised to use effective birth control for men and women taking Doceco 120mg Injection. Women of reproductive potential must use effective contraception during and after six months of therapy. Male patients receiving this Injection treatment should refrain from fathering children and use reliable contraception for six months following the treatment. Inform your healthcare provider if you experience the symptoms of intestinal problems, including stomach pain, tenderness, or diarrhea. Your doctor may suggest regular blood tests to monitor your blood cells and liver function during treatment with this medicine.
References
- 1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707 - 1709. 2. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 866. 3. Seacross Pharma (Europe) Ltd, Electronic medicines compendium (EMC), [ Revised on May 2022] [ Accessed on 26 Nov 2021], https://www.medicines.org.uk/emc/files/pil.7206.pdf 4. Sanofi-aventis US LLC, US Food and Drug Administration, [ Revised on May 2020] [ Accessed on 26 Nov 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020449s084lbl.pdf 5. Angela M Davies et al; Docetaxel in non-small cell lung cancer: a review; Expert Opinion on Pharmacotherapy; Published on April 2003; Accessed on 26/09/2022; https://pubmed.ncbi.nlm.nih.gov/12667118/ 6. Katherine A Lyseng-Williamson, Caroline Fenton; Docetaxel: a review of its use in metastatic breast cancer; Drugs; Published on 2005; Accessed on 26/09/2022; https://pubmed.ncbi.nlm.nih.gov/16296875/
Safety Advice
Pregnancy: Unsafe It is unsafe to use during pregnancy as it may cause harmful effects on the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and six months after the final dose.
Lungs: Consult Your Doctor Inform your physician if you have any lung problems before the treatment with Doceco 120mg Injection.
Breastfeeding: Unsafe It is not recommended to breastfeed during the treatment with Doceco 120mg Injection and for one week after the last dose.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.